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Abstract
Background: Nutritional iron deficiency may limit iron availability to the malaria parasite reducing infection risk,
and/or impair host immunity thereby increasing this risk. In pregnant women, there is evidence of an adverse
effect with iron supplementation, but the few reported studies are strongly confounded.
Methods: A case control study in pregnant Malawian women was undertaken in Chikhwawa southern Malawi in
order to describe iron status in relation to placental malaria controlling for several confounding factors. Pregnancy
characteristics were obtained and a blood sample at delivery. A full blood count was performed and serum ferritin
and transferrin receptor quantified by enzyme-linked immunoassay. DNA analysis was used to identify genetic
polymorphisms for ABO phenotype, hemoglobin HbS, and glucose -6 phosphate dehydrogenase deficiency.
Placental tissue was obtained and malaria histology classified as active, past or no malaria infection.
Results: 112 cases with placental malaria were identified and 110 women with no evidence of placental infection.
Iron deficiency was less frequent in women with placental Plasmodium falciparum infection. In those with acute,
chronic or past placental infections the odds ratio for iron deficiency was 0.4, 95% CI 0.2-0.8, p = 0.01; for acute
and chronic infections 0.4, 0.2-0.8, p = 0.006; for acute infection 0.3, 0.1-0.7, p = 0.001. The association was greater
in multigravidae.
Conclusion: Women with either acute, or acute and chronic placental malaria were less likely to have iron
deficiency than women without placental malaria infection There is a priority to establish if reversing iron
deficiency through iron supplementation programs either prior to or during pregnancy enhances malaria risk.
Background
The influence of iron deficiency on infection risk has
been a long-standing clinical concern [1], related to the
concept that restriction of availability of iron for growth
of pathogens will inhibit pathogen proliferation, and
conversely making iron available would increase infec-
tion risk [2]. A recent Cochrane analysis of 68 trials of
iron supplementation observed an increased risk of
malaria with iron in trials that did not provide malaria
surveillance and treatment [3]. The Cochrane review did
not include studies of pregnant women, yet there are
85.3 million pregnancies in areas with Plasmodium falci-
parum transmission, 54.7 million of which occur in
areas with stable transmission and 30.6 million in areas
with unstable transmission [4].
Iron-malaria interactions in young non-pregnant
women also have been little studied and it is unknown
whether improving iron status of young women prior to
pregnancy living in malaria endemic areas would
increase their risk for pregnancy related malaria. Weekly
iron and folic acid supplementation for all women of
child-bearing age also has been recommended by the
World Health Organization [5], although the safety of
this strategy in terms of malaria risk has not been
assessed.
Only five published studies on the effects of iron treat-
ments or status during pregnancy on the prevalence of
maternal malaria have been identified [6-10]. One
showed an association of recent haematinic use with
increased risk of Plasmodium vivax infection which was
not related to parity [6], another no association of hae-
matinics with placental P. falciparum infection in multi-
gravidae with HbAS genotype [7]. Two uncontrolled
studies reported parenteral iron given to severely
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anaemic women was associated with higher risk of
P. falciparum malaria at delivery [8,9], one of which
reported the association in primiparae, but not multi-
parae [9] As these women receiving parenteral iron all
had severe antenatal anaemia, they would be the more
likely to have malaria at the time of treatment and deliv-
ery independent of iron prescription. A single cross-
sectional study at delivery reported iron deficiency was
associated with decreased the risk of placental parasitae-
mia especially in the first pregnancy [10].
Multigravidae have reduced prevalence of P. falciparum
infection, which is attributed to parity specific immunity
to malaria [11], although as they have higher risk of iron
deficiency due to the cumulative iron needs of successive
pregnancies, then their iron status could influence their
immunity to malaria. Other factors, including ABO blood
group phenotype [12] and adolescence, are also important
for defining malaria risks in pregnancy [13]. The rationale
for the present study was to determine the association of
iron deficiency at delivery with placental malaria control-
ling for these factors, as well as using a histological classifi-
cation of placental malaria which characterizes acute,
chronic, and past placental infections.
Methods
Study sample
This was a case control study conducted between Janu-
ary and July 2005 at Montfort Hospital, in Southern
Malawi amongst all pregnant women who attended the
hospital for delivery and who provided informed con-
sent. Malaria was highly endemic in this area and trans-
mission occurred year round but intensifies during the
rainy season from April to December. A total of 647
women were enrolled who attended the hospital for
delivery. Women were approached during the first stage
of labour and informed consent was requested for parti-
cipation. A questionnaire was completed by a trained
midwife requesting information on age, parity, literacy,
obstetric history, bed net and anti-malarial use. Women
with emergency obstetric problems (toxaemia, haemor-
rhage, obstructed labour or sepsis), or with recent blood
transfusion were excluded. Maternal mid-upper-arm-
circumference (MUAC) was measured at the mid-point
of the left arm.
Following delivery of placenta a tissue sample was
obtained by cutting a one cm cube of tissue from both
the central and peripheral cotyledons. These were fixed
in 10% neutral buffered formalin. Biopsies were
embedded in paraffin wax, sliced into thin sections and
stained with Giemsa and/or haematoxylin and eosin.
Slides were examined at the Histopathology Depart-
ment, College of Medicine, Blantyre, by two observers,
with discrepant findings assessed by a pathologist. Cases
were women with placental malaria, and controls those
with no evidence of infection. Placental malaria was his-
tologically classified as acute, based on the presence of
parasites, chronic, based on the presence of parasites
and haemozoin, and past infection if haemozoin alone
was present. Active infection included both acute and
chronic categories [14].
Study procedures
A maternal peripheral blood sample was obtained after
delivery and placed in a EDTA tube. Thick and thin
blood smears were stained with Giemsa and screened
for malaria parasites. A full blood count was performed
by an automated Beckman Coulter AcT 8 S/N.
AA322060 (http://www.coulter.com). Ferritin and sTfR
were quantified by enzyme-linked immunoassays (http://
www.omegadiagnostics.co.uk;http://www.oriondiagnos-
tica.fi). Iron deficiency was defined as a sTfR:log ferritin
ratio > 1.6, as this cut-off has been shown to best pre-
dict iron deficiency based on bone marrow iron stores
in Malawi, an area with high infection pressure [15].
DNA analysis was used to identify maternal genetic
polymorphisms: ABO blood group, sickle cell poly-
morphism (HbS), and glucose -6-phosphate dehydrogen-
ase deficiency (G6PD). Polymerase chain reactions
(PCRs) were analysed by restriction fragment length
polymorphism technique using restriction enzymes
NlaIII and DdeI for G6PD and HbS respectively. All
RFLPs were electrophoresed for 45 minutes on 2.5%
agarose gel stained with ethidium bromide and visua-
lized with a UVP GelDoc - It imaging system, USA.
Maternal parity was included in the analysis as a
known correlate of placental malaria risk. Adolescence
was defined as < 20 years. Chi-square, Mann-Whitney
and student t tests were used for comparisons using
SPSS version 18. Multivariate logistic regression was
used to describe factors associated with placental
malaria.
Results
Between February-June 2004 and January-July 2005 a
total of 112 infected cases were identified who were
compared with the first 110 women identified with no
evidence of placental infection. Over 95% of women had
received one or more doses of sulphadoxine-pyrimetha-
mine as intermittent treatment (IPTp-SP). There were
no significant differences between cases and controls for
the following parameters: mean age and parity, propor-
tion with low mid-upper arm circumference (< 23 cm),
marital or literacy status, adolescents, frequency of use
of insecticide treated bed nets or uptake of IPTp-SP
during pregnancy (all p > 0.1). 44.1% of cases and 42.5%
of controls were anaemic (Hb < 11g/dl), There were no
differences between cases and controls in prevalence of
severe anaemia (Hb < 8 g/dl, mean 5.9%), G6PD
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deficiency (mean 18.7%), or sickle cell trait (mean
44.5%), (all p > 0.3).
Blood group O phenotype was less frequent in multi-
gravidae with active (35.4%, p = 0.037), or acute infec-
tion (34.8%, p = 0.03) than controls (54.8%), while the
converse was true for primigravidae (61.5%, p = 0.06;
and 63.2%, p = 0.09; versus 37.1%). Sera was available
for iron biomarkers for 92 cases and 68 controls. Of
cases 57.6% had acute, 9.8% chronic, and 32.6% past
infection. Women with either acute (p = 0.001), or
acute and chronic (p = 0.006) placental malaria were
less likely to have iron deficiency than women without
placental malaria infection (Table 1). For all infection
categories (acute, chronic, past) the odds ratio for iron
deficiency was 0.4 (95% CI 0.2-0.8, p = 0.01). Iron defi-
cient multigravidae, but not primigravidae, were less
likely to have placental malaria (all infection categories,
p = 0.002) (Table 1).
Three models were used for the regression analysis,
each for a placental malaria category (all categories,
active, or past). Factors in the model were those with
P < 0.1 in univariate analysis. These were iron defi-
ciency, parity, ABO phenotype and adolescence. Risk of
iron deficiency was reduced for combined infection cate-
gories (p = 0.008), active infection (p = 0.007), or acute
infection (p = 0.001)(Table 2). In multigravidae there
was reduced risk of malaria infection for all infection
categories (p=0.03). Active infection was increased in
adolescents (p=0.04).
Discussion
Iron deficiency was less frequent in women with evi-
dence of acute or chronic placental malarial infection
indicating that women with placental infection have bet-
ter iron status than those without. There was no
difference in use of IPTp-SP during pregnancy between
cases and controls, and the association remained highly
significant controlling for maternal ABO phenotype.
The importance of these results relates to the influ-
ence which maternal iron status has on parity specific
malaria immunity, especially as the results were most
significant for multigravidae. The cumulative iron
requirements of successive pregnancies would increase
prevalence of iron deficiency leading to reduced risk for
placental malaria in multigravidae. As there is a need to
supplement these women with iron this is likely to
increase malaria risk despite acquisition of parity specific
malaria immunity. These results support the findings
from a study in Tanzania based on intervillous blood
smears although that study reported malaria was less
prevalent among women with iron deficiency especially
during the first pregnancy [9]. It will be important to
establish the relative importance of differences in iron
effects between parity groups in a much larger study in
order to determine confounding effects on parity speci-
fic malarial immunity, and in relation to differential
effects on malaria risk of iron supplementation in
pregnancy.
The calculation of body iron store based on the sTfR:SF
ratio provides the best estimate of iron status in adult
men and non-pregnant women in populations where
infectious disorders are not prevalent. Its utility where
women are living under endemic conditions for malaria
is less clear and in severely anaemic HIV infected adults
had low sensitivity based on bone marrow iron stores
[16]. It has good sensitivity and specificity (> 70%) for
reduced bone marrow iron stores in Malawian children
with severe anaemia (Hb < 5g/dl) irrespective of the pre-
sence of infection [15]. The prevalence of iron deficiency
in all women was not high (47.8%), although similar to a
Table 1 Risk of iron deficiency in cases and controls
CASES CONTROLS
Iron Status All infected Active (acute+ chronic) Acute Infection Past Infection No Infection
n/N (%) n/N (%) n/N (%) n/N (%) n/N (%)
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Iron deficiency: primigravidae and multigravidae 44/92 (47.8) 28/62 (45.2) 21/53 (39.6) 16/30 (53.3) 47/68 (69.1)
0.4 (0.2-0.8) 0.4 (0.2-0.8) 0.3 (0.1-0.7) 0.5 (0.2-1.3)
p = 0.01 p = 0.006 p = 0.001 p = 0.13
Iron deficiency: primigravidae 20/37 (54.1) 13/24 (54.2) 8/17 (47.1) 7/13 (53.8) 9/16 (56.3)
0.9 (0.3-3.5) 0.9 (0.3-3.9) 0.7 (0.1-3.4) 0.9 (0.2-5.1)
p = 0.9 p = 0.9 p = 0.8 p = 0.9
Iron deficiency: multigravidae 24/55 (43.6) 15/38 (39.5) 13/36 (36.1) 9/17 (52.9) 38/52 (73.1)
0.3 (0.1-0.7) 0.2 (0.1-0.6) 0.2 (0.1-0.6) 0.4 (0.1-1.5)
p = 0.002 p = 0.002 p = 0.001 p = 0.1
N 92 62 53 30 68
All infected = acute, chronic and past infection.
OR: odds ratio for infected category versus non-infected.
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previous estimate from this area [17]. Other causes for
anaemia are likely to be important including vitamin A
and B12 deficiencies.
Four hypotheses might explain these effects of iron
status in the context of malaria. These are: the availabil-
ity of non-transferrin bound iron which might influence
the growth of the malaria parasite which may be an
acute effect related to recent iron intake or supplemen-
tation; an effect on the oxidant/anti-oxidant balance and
oxidative free radical reactions in the placental intervil-
lous blood which may alter cellular immune function
and macrophage iron metabolism; altered expression of
vascular endothelial molecules which may influence
adhesion and sequestration of P.falciparum parasites;
and altered erythropoiesis with down regulation of para-
site invasion of young red cells.
All these women received haematinics of iron (60 mg)
and folic acid (5 mg) in short daily courses mostly in
the second half of pregnancy. Women were not routi-
nely screened for anaemia at first antenatal attendance
or during pregnancy and there was no preferential pre-
scription of haematinics for selected women with anae-
mia. This is important because women with malarial
anaemia could receive therapeutic iron supplements for
anaemia treatment, reducing iron deficiency, and then
independent of their iron status, these same women
may be more likely to have placental malaria due to a
higher malaria exposure risk. Although the possibility
that some women received additional iron treatments
cannot be excluded, the number was nevertheless likely
to be small and the policy was to uniformly prescribe
haematinics to all women.
This study needs to be replicated in women living
under different levels of malaria transmission in order
to determine the magnitude of these effects in subjects
with different levels of malaria immunity. The small
sample size and lack of available sera from all subjects
limited detailed sub-analyses, for example, placental
malaria iron interactions in younger adolescents less
than 16 years. A large multi-centre case control study is
required to adequately address this.
As many millions of pregnant women are exposed to
malaria annually there is a priority to establish if rever-
sing such iron deficiency states through routine sup-
plementation programs either prior to or during
pregnancy enhances malaria risk especially in areas
where malaria control and surveillance is limited. It is
particularly important to assess this in adolescents as
their malaria immunity is lower than that in older
women and many will experience pregnancy while still
adolescent.
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